Evidence map›Paper›PMID 35630668›Full record

ArticleMolecules (Basel, Switzerland)2022

Non-Alcoholic Fatty Liver Disease in Long-Term Type 2 Diabetes: Role of rs738409

Mauy Frujuello Mana, Maria Cândida R Parisi, Maria Lucia Correa-Giannella, Arnaldo Moura Neto, Ademar Yamanaka, Marlone Cunha-Silva, Ana Mercedes Cavaleiro, Cristina Rodrigues Dos Santos, Célia Regina Pavan, Tiago Sevá-Pereira and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Global Epidemiology and Implications ofJournal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Mauy Frujuello ManaDivision of Gastroenterology (Gastrocentro), Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.
Maria Cândida R ParisiDivision of Endocrinology, Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-887, SP, Brazil.
Maria Lucia Correa-GiannellaLaboratório de Carboidratos e Radioimunoensaios (LIM-18), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.ORCID 0000-0003-3655-4446
Arnaldo Moura NetoDivision of Endocrinology, Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-887, SP, Brazil.
Ademar YamanakaDivision of Gastroenterology (Gastrocentro), Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.
Marlone Cunha-SilvaDivision of Gastroenterology (Gastrocentro), Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.
Ana Mercedes CavaleiroLaboratório de Carboidratos e Radioimunoensaios (LIM-18), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo 01246-903, SP, Brazil.
Cristina Rodrigues Dos SantosDivision of Gastroenterology (Gastrocentro), Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.
Célia Regina PavanDivision of Gastroenterology (Gastrocentro), Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.
Tiago Sevá-PereiraDivision of Gastroenterology (Gastrocentro), Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.ORCID 0000-0002-3282-8019
Sergio S J DertkigilDepartment of Radiology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-887, SP, Brazil.
Daniel F MazoDivision of Gastroenterology (Gastrocentro), Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-878, SP, Brazil.ORCID 0000-0002-2164-2630
Universidade Estadual de Campinas (UNICAMP) · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRUniversidade de São Paulo · BR

Funding

São Paulo Research Foundation 2018/17333-6
6 · The paper itself

Abstract

Fibroblast growth factor 21 (FGF21) signaling and genetic factors are involved in non-alcoholic fatty liver disease (NAFLD) pathogenesis. However, these factors have rarely been studied in type 2 diabetes mellitus (T2D) patients from admixed populations such as in those of Brazil. Therefore, we aimed to evaluate rs738409 patanin-like phospholipase domain-containing protein (

Indexed as

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseAcyltransferasesBiomarkersFibroblast Growth FactorsHumansLipaseLiver CirrhosisMembrane ProteinsPhospholipases A2, Calcium-IndependentAcyltransferasesBiomarkersFGF21 protein, humanfibroblast growth factor 21Fibroblast Growth FactorsLipaseMembrane ProteinsPhospholipases A2, Calcium-IndependentPNPLA3 protein, humanbiomarkerselastographygenetic polymorphismsliver fibrosisnon-alcoholic fatty liver diseasetype 2 diabetes

Identifiers

PMID35630668
PMCPMC9143959
OpenAlexW4280510966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.